Viridian Therapeutics, Inc.\DE insider trading
VRDN$18.22-0.78 (-4.11% today)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Oct 6, 2025 to Oct 6, 2026. Price (-12.5%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Unlock quarterly net flowKey players
- RTRadhika Tripuraneni0.0353%
- SFStephen F. Mahoney0.0294%
- TWThomas W. Beetham0.0118%
- SHSeth Harmon0.0069%
- JTJennifer Tousignant0.00%
- FFFairmount Funds Management LLCNot reported
- FHFairmount Healthcare Fund II L.P.Not reported
- FHFairmount Healthcare Fund II GP LLCNot reported
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| VRDN | Fairmount Healthcare Fund II L.P. | Open market purchase$20M | +30.1% | $17.00 | $20M | May 11, 2026 | May 13, 2026 |
| VRDN | Jennifer Tousignant | Open market sell$70.8K | -100.0% | $31.16 | $70.8K | Dec 31, 2025 | Jan 2, 2026 |
| VRDN | Fairmount Healthcare Fund II GP LLC | Open market purchase$10M | +13.1% | $22.00 | $10M | Oct 23, 2025 | Oct 27, 2025 |